GlaxoSmithKline Pharmaceuticals informs about secretarial compliance report

15 May 2025 Evaluate

In compliance with the provisions of Regulation 24A of SEBI LODR Amendment Regulations, 2018, read with SEBI Circular dated February 08, 2019, GlaxoSmithKline Pharmaceuticals has informed that it enclosed Annual Secretarial Compliance Report of the Company for the financial year ended 31st March 2025.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2598.00 -25.95 (-0.99%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×